Mira Pharmaceuticals MIRA
NASDAQ MIRA
$0.63 -0.05 (-7.76%)
As of: Oct 22, 2026 · 3:59 PM EDT

Mira Pharmaceuticals (MIRA) Receivables (2023 - 2024)

Updated

Mira Pharmaceuticals' Receivables was $40,439 in the quarter ended Dec 31, 2024, up 139.8% from $16,862 a year earlier.

Analysis

Mira Pharmaceuticals (MIRA) Receivables (2023 - 2024) Analysis & Trends

  • In earlier years, Receivables was $16,862 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 18.99 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 13.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 15.68 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 5.06 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 12.49 Bn
10 Mira Pharmaceuticals 14.90 Mn -5.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 40,439.00
Dec 31, 2023 16,862.00
API Access

Mira Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=MIRA&period=max&api_key=YOUR_API_KEY